| Q40900445 | A case study evaluating the use of clozapine in depression with psychotic features |
| Q35665593 | Atypical Antipsychotic Use in the Treatment of Psychosis in Primary Care |
| Q34108447 | Atypical antipsychotic drugs in nonschizophrenic psychiatric disorders |
| Q35073763 | Atypical antipsychotics and mood stabilization in bipolar disorder |
| Q36518167 | Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability |
| Q41241532 | Clinically significant interactions of psychotropic agents with antipsychotic drugs |
| Q92403507 | Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports |
| Q37285391 | Clozapine-induced bowel infarction: a case report |
| Q34387550 | Comparative efficacy and tolerability of drug treatments for bipolar disorder |
| Q34057133 | Functional impairment and cognition in bipolar disorder |
| Q36699480 | Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge |
| Q36045493 | Predictors and markers of clozapine response |
| Q35936870 | Starting clozapine in the community: a UK perspective |
| Q33922181 | Treatment of bipolar mixed state with olanzapine. |